JPS549265A - Composition and method - Google Patents

Composition and method

Info

Publication number
JPS549265A
JPS549265A JP7102278A JP7102278A JPS549265A JP S549265 A JPS549265 A JP S549265A JP 7102278 A JP7102278 A JP 7102278A JP 7102278 A JP7102278 A JP 7102278A JP S549265 A JPS549265 A JP S549265A
Authority
JP
Japan
Prior art keywords
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7102278A
Other languages
English (en)
Inventor
Reonaado Bandei Goodon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of JPS549265A publication Critical patent/JPS549265A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
JP7102278A 1977-06-17 1978-06-14 Composition and method Pending JPS549265A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/807,514 US4097489A (en) 1977-06-17 1977-06-17 9-Deoxy-9α,6-nitrilo or 6,9α-imino-PGF compounds

Publications (1)

Publication Number Publication Date
JPS549265A true JPS549265A (en) 1979-01-24

Family

ID=25196557

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7102278A Pending JPS549265A (en) 1977-06-17 1978-06-14 Composition and method

Country Status (16)

Country Link
US (6) US4097489A (ja)
JP (1) JPS549265A (ja)
AU (1) AU520091B2 (ja)
BE (1) BE868202A (ja)
CA (1) CA1091227A (ja)
CH (1) CH635075A5 (ja)
DE (1) DE2826096A1 (ja)
FR (1) FR2394530A1 (ja)
GB (1) GB1598137A (ja)
IE (1) IE47199B1 (ja)
IL (1) IL54806A (ja)
IT (1) IT1158739B (ja)
NL (1) NL7806383A (ja)
NZ (1) NZ187393A (ja)
SE (1) SE7806927L (ja)
ZA (1) ZA783065B (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55111465A (en) * 1979-02-20 1980-08-28 Ono Pharmaceut Co Ltd Prostaglandin i2 analog and its preparation
JPS56111811A (en) * 1980-02-11 1981-09-03 Toshiba Corp Light signal branching device

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097489A (en) * 1977-06-17 1978-06-27 The Upjohn Company 9-Deoxy-9α,6-nitrilo or 6,9α-imino-PGF compounds
JPS54125653A (en) * 1978-03-18 1979-09-29 Ono Pharmaceut Co Ltd Prostaglandin i2 analog, its preparation, and drug composition comprising it as active constituent
US4211706A (en) * 1978-10-13 1980-07-08 The Upjohn Company 9-Deoxy-9α,6-nitrilo or 6,9α-imino-17,18-didehydro-PGF compounds
DE2845770A1 (de) * 1978-10-19 1980-04-30 Schering Ag Neue prostacyclin-derivate und verfahren zu ihrer herstellung
DE2907118A1 (de) * 1979-02-20 1980-09-04 Schering Ag Neue prostacyclin-derivate und verfahren zu ihrer herstellung
US4294759A (en) * 1979-11-15 1981-10-13 The Upjohn Company Structural analogues of 5,6,-dihydro PG1
DE3006865A1 (de) * 1980-02-23 1981-09-10 Hoechst Ag, 6000 Frankfurt Hetero-imino-prostacycline
EP0054795B1 (en) * 1980-12-09 1987-07-15 Teijin Limited Novel halogenated prostacyclins, process for the production thereof, and pharmaceutical use thereof
DE3107100A1 (de) * 1981-02-20 1982-09-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen Azaprostacycline, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
IE52937B1 (en) * 1981-04-02 1988-04-13 Searle & Co 5 fluoro pgi compounds
US4702261A (en) * 1985-07-03 1987-10-27 Sherwood Medical Company Biopsy device and method
US6187813B1 (en) 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
ES2213504T1 (es) 1988-09-06 2004-09-01 Pfizer Health Ab Derivados de prostaglandina para el tratamiento del glaucoma o hipertension ocular.
US5972991A (en) * 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
EP0664707B1 (en) * 1992-10-13 1997-06-04 Alcon Laboratories, Inc. Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma
US5332730A (en) * 1992-10-16 1994-07-26 Allergan, Inc. Azido derivatives of cyclopentane heptanoic or heptenoic acid
US6294563B1 (en) 1994-10-27 2001-09-25 Allergan Sales, Inc. Combinations of prostaglandins and brimonidine or derivatives thereof
US5700835A (en) * 1995-12-22 1997-12-23 Alcon Laboratories, Inc. 3-Oxa-D-prostaglandins for lowering IOP
AU7680096A (en) * 1995-12-22 1997-07-17 Alcon Laboratories, Inc. Combinations of dp and fp type prostaglandins for lowering iop
US7718697B2 (en) * 2003-12-17 2010-05-18 Alcon, Inc. Method for treating glaucoma comprising administering α-lipoic acid

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931289A (en) * 1970-12-31 1976-01-06 The Upjohn Company 3-Oxa phenyl-substituted PGE compounds
US3772312A (en) * 1972-01-31 1973-11-13 Ciba Geigy Corp Octahydropyrindenes
US3983157A (en) * 1974-04-11 1976-09-28 The Upjohn Company 4-Oxa phenyl-substituted PGF compounds
US3983158A (en) * 1974-04-11 1976-09-28 The Upjohn Company 3-Oxa phenyl-substituted PGA compounds
US4324905A (en) * 1974-08-14 1982-04-13 The Upjohn Company Phenacyl-type esters of PGF2α and its 15-methyl analogs
GB1529852A (en) * 1975-03-21 1978-10-25 Labaz 8-azaprostaglandins and process for the preparation thereof
GB1523178A (en) * 1975-04-26 1978-08-31 Tanabe Seiyaku Co 8-azaprostanoic acid derivatives and process for preparing the same
US3983178A (en) * 1975-07-21 1976-09-28 Hooker Chemicals & Plastics Corporation Immonium salts and derivatives thereof
US4097489A (en) * 1977-06-17 1978-06-27 The Upjohn Company 9-Deoxy-9α,6-nitrilo or 6,9α-imino-PGF compounds

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55111465A (en) * 1979-02-20 1980-08-28 Ono Pharmaceut Co Ltd Prostaglandin i2 analog and its preparation
JPS6228134B2 (ja) * 1979-02-20 1987-06-18 Ono Pharmaceutical Co
JPS56111811A (en) * 1980-02-11 1981-09-03 Toshiba Corp Light signal branching device

Also Published As

Publication number Publication date
US4161584A (en) 1979-07-17
DE2826096A1 (de) 1979-01-04
NL7806383A (nl) 1978-12-19
NZ187393A (en) 1981-12-15
AU3655778A (en) 1979-12-06
FR2394530B1 (ja) 1981-02-27
GB1598137A (en) 1981-09-16
US4097489A (en) 1978-06-27
IT7824093A0 (it) 1978-05-31
US4152514A (en) 1979-05-01
US4151176A (en) 1979-04-24
US4163841A (en) 1979-08-07
IE47199B1 (en) 1984-01-11
AU520091B2 (en) 1982-01-14
CA1091227A (en) 1980-12-09
BE868202A (fr) 1978-12-18
CH635075A5 (de) 1983-03-15
FR2394530A1 (fr) 1979-01-12
IE781222L (en) 1978-12-17
SE7806927L (sv) 1979-12-16
US4136095A (en) 1979-01-23
ZA783065B (en) 1979-06-27
IL54806A (en) 1984-02-29
IT1158739B (it) 1987-02-25

Similar Documents

Publication Publication Date Title
JPS5464695A (en) Substance composition and method
JPS5416453A (en) Composition and method
JPS54160403A (en) Washhbleaching composition and method
JPS5223064A (en) Composition and method
JPS5440850A (en) Binder composition and its making method
JPS5295644A (en) Composition and method
JPS5440961A (en) *sakatoge** and method for manufacturing same
JPS549265A (en) Composition and method
GB2000030A (en) Bacteriostatic composition and method
JPS53139730A (en) Pharmaceutical composition and method
JPS53141292A (en) Novel imidazoazine and * imidazodiazine
GB2007216B (en) Isochromans siothiochromans 2-benzoxepins and benzothieps
JPS54102394A (en) Heattcurable composition and curing method
JPS532464A (en) Composition and method
JPS5492953A (en) Composition and method
JPS5392951A (en) Stabilized heattabsorbing composition and absorptionn heating method
JPS53127383A (en) Scale controlling composition and controlling method
JPS5441851A (en) Arylphosphonite and thiophosphonite
JPS53111095A (en) Pyroloquinoxalines and pyrolobenzodiazepinons
JPS5452067A (en) Arylphosphonite and thiophosphonite
JPS5498719A (en) Novel tetrapeptide and its method
AU3972178A (en) Prostaglandin composition and method
JPS53103497A (en) Heterocyclopyrimidines composition and treating method
JPS53120754A (en) Fillerrcontaining composition and method of making same
JPS54147923A (en) Novel composition and method